Skip to main content
Clinical Trials/IRCT201101125596N1
IRCT201101125596N1
Completed
未知

Comparison of administration of supplemental oxygen on nausea and vomiting in patients undergoing spinal anesthesia for elective cesarean section

orestan University of Medical Sciences and Health Services0 sites120 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Complications of anaesthesia during labour and delivery.
Sponsor
orestan University of Medical Sciences and Health Services
Enrollment
120
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
orestan University of Medical Sciences and Health Services

Eligibility Criteria

Inclusion Criteria

  • Elective cesarean section and fasting for 6\-8 hours before and 6 hours after surgery.
  • Exclusion criteria:
  • Need to general anesthesia or having sever vomiting, symptomatic gastrointestinal disease, motion sickness, dizziness, heart disease, cardiovascular and pulmonary disease, middle ear diseases, diabetes mellitus, infectious disease, fever, hypertension, smoking, alcohol consumption, immunosuppressive medications, bleeding, hemoglobin less than 10 mg dl and another medications other antibiotics.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Comparison of Supplemental Oxygen and Nitric Oxide for Inhalation Plus Oxygen in the Evaluation of the Reactivity of the Pulmonary Vasculature During Acute Pulmonary Vasodilator Testing - N/Aitric Oxide for inhalation at 800ppm, plus 100% O2, to be used to assess pulmonary vaso reactivity during Pulmonary Vasodilator Testing
EUCTR2004-000625-30-GBINO Therapeutics150
Active, not recruiting
Phase 1
Comparison of Supplemental Oxygen and Nitric Oxide for Inhalation Plus Oxygen in the Evaluation of the Reactivity of the Pulmonary Vasculature During Acute Pulmonary Vasodilator Testing - N/A: Nitric Oxide for inhalation at 800ppm, plus 100% O2, to be used to assess pulmonary vaso reactivity during Pulmonary Vasodilator Testing
EUCTR2004-000625-30-ESINO Therapeutics
Not yet recruiting
Phase 3
Comparison of three techniques of giving oxygen during flexible bronchoscopy in childreHealth Condition 1: J988- Other specified respiratory disorders
CTRI/2024/03/063406AIIMS NEW DELHI
Recruiting
Not Applicable
Comparison of effects of oxygen supplementation at different flow rates versus no oxygen supplementation during flexible bronchoscopy
CTRI/2023/03/051173Kasturba medical college Manipal
Completed
Phase 1
Comparing effect of supplemental oxygen on patient oxygenation status compared to standard technique during general anaesthesia administratioHealth Condition 1: Z768- Persons encountering health services in other specified circumstances
CTRI/2020/07/026723Mosc Medical college71